Navigation Links
New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target

Dr. Jim Kim joins teleconference to release report with ITPC. Kim says foundations laid by AIDS response are "the best chance we've ever had to build comprehensive health systems in the poorest settings."

NEW YORK AND CAPE TOWN, South Africa, Nov.27 /PRNewswire-USNewswire/ -- The International Treatment Preparedness Coalition (ITPC), a group of 1,000 treatment activists from more than 125 countries, today issued its fifth report on scale up of AIDS services: Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All. The report is available at

The comprehensive report investigates AIDS drug access in 14 countries and finds that scale up is working but high prices, patent and registration barriers, and ongoing stock-outs are core issues impeding better and faster AIDS drug delivery.

"The foundations to make the 2010 target are in place in many countries. If governments, global agencies, and drug companies focus on tactically improving AIDS drug access by continually lowering costs, ending patent and regulatory problems, and fixing drug availability logistics, while simultaneously strengthening health systems, there is real possibility for making the 'near universal access' target by 2010," said Gregg Gonsalves, a coordinator of the project.

Missing the Target teams in nine countries -- Cambodia, Cameroon, China, Dominican Republic, India, Kenya, Russia, Zambia, and Zimbabwe -- also looked at broader issues in AIDS service delivery in their countries. "AIDS treatment scale up cannot succeed without stronger health systems, adequate nutrition, and concerted action against stigma and marginalization," said Matilda Moyo of the Zimbabwe research team.

"Mobilization around AIDS has opened up fantastic new possibilities in health service delivery by infusing new resources, intensifying the engagement of people living with HIV/AIDS, and focusing on specific, measurable outcomes," said Dr. Jim Yong Kim, Director of the Francois-Xavier Bagnoud Center for Health and Human Rights (FXB) at Harvard University. "We must learn from and build on these foundations because they represent the best chance we've ever had to build comprehensive health systems in the poorest settings."

"It is irresponsible to get bogged down in debates on simplistic dichotomies like prevention versus treatment or disease-specific funding versus strong health systems. We can, and we must, do all of this, better, for more people, and in an increasingly coherent way," added Chris Collins, a coordinator of the project.

"The UNAIDS epidemiologic estimates released last week show that we're getting closer to reaching the goal of treatment for all," said Shona Schonning of the Russia research team. "The UNAIDS report shows that prevention and treatment programming have had impact. Now its time to scale up these programs and continue to make progress on what remains a devastating epidemic."

In the report, civil society advocates in 14 countries identify specific problems and recommend solutions to improve AIDS drug access:

-- In Argentina, high cost and restrictions on some drugs impede access to some second line and other medicines.

-- In Belize, human resources shortfalls, price increases and inadequate quality assurance hamper drug delivery.

-- In Cambodia, expanded access to drug resistance and viral load testing is needed, as is increased attention to drug quality.

-- In China, access to second-line therapy is extremely limited, new WHO treatment guidelines on improved first-line treatment have not been widely implemented and patents on key medicines are preventing cost-cutting generic competition.

-- In the Dominican Republic, new intellectual property laws and patent enforcement by Merck are leading to higher prices and limited access to some key drugs.

-- In India, drug stock-outs are reported across the country, particularly where IDUs require treatment regimens that are not hepatotoxic.

-- In Malawi, a chronic shortage of health care workers is a major impediment to drug access; while ARV stock-outs are rare, other important drugs are often unavailable.

-- In Morocco, new intellectual property laws threaten the provision of AIDS treatment.

-- In Nigeria, despite a rapid scale up of ARV treatment and a free treatment policy, treatment sites are not easily accessible in many parts of the country, and CD4 and other tests are still being offered at a fee in several locations.

-- In the Philippines, treatment is not yet accessible to all, there is a healthcare worker shortage and diagnostic testing access is limited.

-- In Russia, ARV stock-outs are a severe and ongoing problem.

-- In Uganda, stock-outs are commonplace, and limited support and care services undermine drug access.

-- In Zambia, there is concern that AIDS drug access depends on the work of NGOs and the government is not sufficiently engaged.

-- In Zimbabwe, stock-outs are frequent and the increasingly unfriendly general policy environment remains a cause for concern.

Action Recommendations for Global Agencies and National Governments

-- The World Health Organization: Take the lead to educate countries about changes to standard first- and second-line treatment regimens and lead global efforts to simultaneously expand AIDS services while strengthening broader care systems.

-- United Nations technical agencies: Clearly and publicly communicate changes in WHO ARV drug guidelines and provide technical support and guidance to countries to help implement the changes.

-- The Global Fund: Proactively support grantees in identifying and correcting procurement bottlenecks and strengthening national procurement systems for ARVs and other medicines and ensure grantees are procuring medicines at preferential prices.

-- Bilateral programs (PEPFAR, etc.): Work with national treatment programs, community organizations, PLWHA and other partners to support national efforts to switch to optimized first-line treatment.

-- UNITAID (the international drug purchase facility): Work aggressively to support initiatives to increase competition and further reduce the price of new standardized treatment regimens.

-- Drug companies: Act with enlightened self-interest to expand access to products by registering them much more expeditiously and stop intimidating countries that use flexibilities in trade law.

-- National governments: Build local and regional drug regulatory capacity, make fuller use of the WHO drug prequalification process, and use flexibilities in international trade rules to secure the lowest possible drug prices.

About the International Treatment Preparedness Coalition

The International Treatment Preparedness Coalition (ITPC) was born out of the International Treatment Preparedness Summit that took place in Cape Town, South Africa in March 2003. That meeting brought together for the first time community-based HIV treatment activists and educators from over 60 countries. Since the Summit, ITPC has grown to include more than 1,000 activists from over 125 countries and has emerged as a leading civil society coalition on treatment preparedness and access issues.

SOURCE International Treatment Preparedness Coalition
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... (PRWEB) , ... November 28, 2015 , ... There is ... we outperform our billings from last year? , This question has not been an ... are coming to the retirement age and the younger workforce don’t share the same ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at ... people age, more care is needed, especially with Alzheimer’s, dementia and other cognitive ... being overworked. The forgotten part of this equation: 80 percent of medical care ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
Breaking Medicine News(10 mins):